Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Parkinson Disease · Anxiety

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Shahid Beheshti University of Medical Sciences, Shohada-e-Tajrish Hospital, Tehran, Iran

    Contact: Study coordinator (Mehri Salari, MDFelloship) · mehri.salari@gmail.com · +989124972186
Study leads
  • Leila Dargahi, PharmD/PhD

    Principal Investigator

    Shahid Beheshti University of Medical Sciences

  • Mehri Salari, MDFellowship

    Principal Investigator

    Shahid Beheshti University of Medical Sciences

  • Neda Valian, PhD

    Study Director

    Shahid Beheshti University of Medical Sciences

  • Leila Mohaghegh Shalmani, PharmD/PhD

    Study Chair

    Shahid Beheshti University of Medical Sciences